LYN HERNANDEZ: Open Payments
NPI 1679300222 · NATIONAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $283 |
| ABBVIE INC. | 8 | $277 |
| Axsome Therapeutics, Inc. | 3 | $264 |
| Otsuka America Pharmaceutical, Inc. | 4 | $158 |
| Neurocrine BioSciences, Inc. | 1 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $90 |
| Alkermes, Inc. | 3 | $58 |
| Luye Pharma (USA) Ltd. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: COBENFY, VRAYLAR, Auvelity, REXULTI, INGREZZA, CAPLYTA, ARISTADA, ERZOFRI EXTENDED-RELEASE.
Industry payments across CA — which companies pay providers there.
